» Articles » PMID: 17115422

Lack of Association of Interleukin-6 and Interleukin-8 Gene Polymorphisms in Chinese Patients with Systemic Lupus Erythematosus

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2006 Nov 23
PMID 17115422
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine whether interleukin (IL)-6 and IL-8 gene polymorphisms were markers of susceptibility to or severity of systemic lupus erythematosus (SLE) in Chinese patients. The study included 150 Chinese patients with SLE. A total of 130 unrelated healthy individuals living in central Taiwan served as control subjects. Polymorphisms of the IL-6 and IL-8 gene were typed from genomic DNA. The genotypes, allelic frequencies, and carriage rates were compared between SLE patients and control subjects. The relationship between allelic frequencies and clinical manifestations of 135 SLE patients was evaluated. There were no statistically significant differences in IL-6 and IL-8 gene polymorphisms between the SLE and control groups (chi-squared test, P=0.53, chi(2)=1.27 and P=0.44, chi(2)=1.62, respectively). In addition, there was no significant association between the two groups in allelic frequency of IL-6 and IL-8 (P=0.89 and P=0.26, respectively). We also did not detect any association between the IL-6 and IL-8 genotype and clinical or laboratory profiles in SLE patients. The results suggest that the IL-6 and IL-8 gene polymorphisms are not related to SLE.

Citing Articles

Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update.

Su H, Lei C, Zhang C Front Immunol. 2017; 8:405.

PMID: 28484449 PMC: 5399081. DOI: 10.3389/fimmu.2017.00405.


Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus.

Silva H, da Silva A, da Silva H, Asano N, Maia M, Souza P Mol Biol Rep. 2014; 41(4):2493-500.

PMID: 24443230 DOI: 10.1007/s11033-014-3106-9.


Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus.

Hristova M, Dourmishev L, Kamenarska Z, Nikolova S, Kaneva R, Vinkov A Biomed Res Int. 2013; 2013:315365.

PMID: 24106699 PMC: 3784074. DOI: 10.1155/2013/315365.


A meta-analysis of the association of IL-6 -174 G/C and -572 G/C polymorphisms with systemic lupus erythematosus risk.

Yang Z, Liang Y, Qin B, Zhong R Rheumatol Int. 2013; 34(2):199-205.

PMID: 24013670 DOI: 10.1007/s00296-013-2855-4.


Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview.

Chai H, Phipps M, Chua K Clin Dev Immunol. 2011; 2012:963730.

PMID: 21941582 PMC: 3176625. DOI: 10.1155/2012/963730.


References
1.
Klinman D, Steinberg A . Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med. 1987; 165(6):1755-60. PMC: 2188353. DOI: 10.1084/jem.165.6.1755. View

2.
Sekikawa T, Kashihara N, Maruyama K, Satoh M, Okamoto K, Kanao K . Expression of interleukin-8 in human glomerulonephritis. Res Commun Mol Pathol Pharmacol. 1998; 99(2):217-24. View

3.
Mukaida N, Shiroo M, Matsushima K . Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol. 1989; 143(4):1366-71. View

4.
Terry C, Loukaci V, Green F . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000; 275(24):18138-44. DOI: 10.1074/jbc.M000379200. View

5.
Ishihara K, Hirano T . IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002; 13(4-5):357-68. DOI: 10.1016/s1359-6101(02)00027-8. View